These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23034783)

  • 1. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
    Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
    Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
    Deutschbein T; Broecker-Preuss M; Flitsch J; Jaeger A; Althoff R; Walz MK; Mann K; Petersenn S
    Eur J Endocrinol; 2012 Apr; 166(4):613-8. PubMed ID: 22214924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated Salivary Cortisol as a Noninvasive Diagnostic Tool for Adrenal Insufficiency.
    Kim YJ; Kim JH; Hong AR; Park KS; Kim SW; Shin CS; Kim SY
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):628-635. PubMed ID: 32981305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
    Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.
    Raff H
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3647-55. PubMed ID: 19602555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
    Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
    Arlt W; Rosenthal C; Hahner S; Allolio B
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring adrenal insufficiency through salivary steroids: a pilot study.
    Tucci L; Fanelli F; Improta I; Bissi V; Lena C; Galante G; Mezzullo M; Magagnoli M; Lalumera AB; Colombin G; Coscia K; Rotolo L; Vicennati V; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2024 Mar; 190(4):327-337. PubMed ID: 38571387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.
    Galbois A; Rudler M; Massard J; Fulla Y; Bennani A; Bonnefont-Rousselot D; Thibault V; Reignier S; Bourrier A; Poynard T; Thabut D
    J Hepatol; 2010 Jun; 52(6):839-45. PubMed ID: 20385427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of salivary cortisol in end stage renal disease.
    Arregger AL; Cardoso EM; Tumilasci O; Contreras LN
    Steroids; 2008 Jan; 73(1):77-82. PubMed ID: 17945323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary cortisol and cortisone in the clinical setting.
    Blair J; Adaway J; Keevil B; Ross R
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):161-168. PubMed ID: 28375882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test.
    Deutschbein T; Unger N; Mann K; Petersenn S
    Eur J Endocrinol; 2009 Jan; 160(1):9-16. PubMed ID: 18952762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K; Thorsen TE; Husebye ES
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency.
    Frigerio S; Carosi G; Ferrante E; Sala E; Polledri E; Fustinoni S; Ambrosi B; Chiodini I; Mantovani G; Morelli V; Arosio M
    Front Endocrinol (Lausanne); 2023; 14():1093838. PubMed ID: 36761196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.